top of page
Search

Electronic Prior Authorization Is Coming. Is Your Practice Ready to Use It?

3 hours ago
6 min read

By Erik Beshlikyan · Adapted from graduate coursework in Healthcare Administration and Policy at Arizona State University

Beginning in 2027, many government-program health plans must be able to receive prior authorization requests electronically. That shift will reduce faxes and phone calls only for practices whose workflows are ready to use it. Research from one large health system shows that switching on electronic prior authorization did not, by itself, get patients their prescriptions faster.

Why this matters now

Under the CMS Interoperability and Prior Authorization Final Rule, known as CMS-0057-F, Medicare Advantage plans, Medicaid and CHIP programs and their managed care plans, and Marketplace plans on the federal exchanges must stand up a standards-based Prior Authorization API. Most of these payers face a January 1, 2027 deadline. The API lets a practice's EHR ask whether an item or service needs authorization, see what documentation the payer requires, and submit the request electronically.

It is easy to read this as the end of the prior authorization problem. Our view is more cautious. Electronic prior authorization, or ePA, changes the channel a request travels through. It does not decide who in the practice watches for the request, who answers the payer, or who follows up when a request stalls. Those decisions determine whether patients actually get care sooner.

What one health system learned

In 2018, Sutter Health, a large health system in Northern California, built electronic prior authorization for prescriptions into its EHR. When a participating pharmacy benefit manager required authorization, prescribers received a message in their EHR inbox. Researchers from Sutter and Brigham and Women's Hospital then measured whether patients filled those prescriptions more often or more quickly. Their study, by Lauffenburger and colleagues in the Journal of the American Medical Informatics Association, compared about 38,900 ePA prescriptions with matched prescriptions for the same drug, insurance plan, and site written before the rollout.

The results were not what most people would expect.

Measure

With ePA

Comparison group

Filled within 30 days, compared with before rollout

64.2%

68.8%

Average days to fill, among filled prescriptions

4.2

3.0

Filled within 30 days, compared with sites not yet live

64.7%

62.3%, not a meaningful difference

The tool also triggered for fewer than 2% of all prescriptions. The authors' conclusion was direct. Adopting ePA did not change whether patients picked up their medications.

The study has real limits, and we want to be fair to it. It was not randomized, so it cannot prove ePA caused the lower fill rate. Its two comparisons did not fully agree. It also measured prescription fills, not staff time, which is one of the main things ePA is meant to save. Still, it is one of the few real-world evaluations of ePA, and its lesson holds up. A digital tool did not fix the access problem on its own.

Why turning it on was not enough

The researchers offered several likely explanations. They did not test these directly, but each one will sound familiar to anyone who has worked a prior authorization queue.

  • Alerts fired inaccurately. The system sometimes flagged prescriptions for authorization inaccurately. Staff learn to distrust an alert that is often wrong.

  • Not every payer participated. Coverage was split across many insurers and benefit managers, so the electronic path worked for some patients and not others.

  • Two processes ran side by side. The electronic workflow sat next to the old phone and fax workflow instead of replacing it, so staff had to track both.

  • Denials went unread. Notices landed in busy EHR inboxes where no one was clearly responsible for acting on them.

The common thread is that ePA moved a fragmented process into a new format without fixing the fragmentation. In our experience with authorization and contact center operations, patient delays usually come from three things. Those are payer rules, incomplete information on the first submission, and unclear ownership of follow-up. Software can make each step faster, but only a redesigned workflow makes sure every step happens.

What actually changes in 2027

The federal rules put most of the technical work on payers, but practices are expected to start using it. Here is where things stand as of November 2026.

  • Payers must offer a Prior Authorization API for medical items and services (final). Applies to Medicare Advantage, Medicaid and CHIP, and Marketplace plans on the federal exchanges. Timing: generally January 1, 2027.

  • Decisions within 72 hours for expedited requests and 7 calendar days for standard requests, with a specific reason for any denial (final). Applies to most of the same payers. Timing: began January 1, 2026.

  • Electronic Prior Authorization measure in MIPS Promoting Interoperability (final). Applies to MIPS-eligible clinicians. Timing: optional bonus worth 10 points in 2027, required in 2028.

  • New Electronic Prior Authorization for Prescription Drugs measure in MIPS (final). Applies to MIPS-eligible clinicians. Timing: required in 2028.

  • Extend the payer API requirements to prescription drugs (proposed only). Would apply to the same payers. Timing: not yet set.

Two limits matter for planning. First, the payer API rule covers medical items and services and excludes drugs. CMS has proposed extending it to drugs, but that is not final. Second, these rules do not reach most commercial employer plans, which carry much of a typical practice's prior authorization volume.

The Sutter study looked at prescriptions, and the 2027 payer requirement covers services such as imaging, procedures, and equipment. The lesson still carries over. Each new electronic channel will run into the same problems of inaccurate triggers, uneven payer participation, parallel processes, and unclear ownership.

A readiness checklist for practices

These steps are the operational work that turns an electronic channel into faster care. Most of them cost staff time rather than money, and most can start before your EHR vendor finishes its part.

  1. Map your prior authorization volume. Sort recent requests by payer and by type, meaning drug versus medical service. That shows how much of your workload the 2027 payer rule will reach and how much will stay manual.

  2. Ask your EHR vendor specific questions. Does your system support FHIR-based prior authorization using the HL7 Da Vinci guides CMS recommends to payers, known as CRD, DTR, and PAS? Which of your payers will be connected, and when? Will the feature support the MIPS Electronic Prior Authorization measure, and what will it cost?

  3. Name an owner for every queue. Send pending requests and denials to a shared work queue with one accountable person, not to individual prescribers' inboxes.

  4. Retire the old process payer by payer. When a payer goes electronic, update your procedures so staff stop working that payer by phone and fax. Keep a clear fallback for payers that are not connected.

  5. Audit the triggers. Each month, review a sample of flagged and unflagged orders to confirm the system is asking for authorization when it should. Report errors to your vendor.

  6. Measure the process as well as adoption. Track the share of requests sent electronically, time from order to submission, time from submission to decision, and time from denial to action. Pair these with patient measures such as prescriptions filled and procedures completed.

  7. Train for the exceptions. Staff need to know exactly what to do when a payer is not connected, a response does not arrive, or a denial needs a peer-to-peer review.

The bottom line

Electronic prior authorization is a real improvement in the channel, and the 2027 deadlines will make it far more common. The Sutter Health experience shows that the channel is only part of the answer. Practices that assign ownership, retire duplicate work, and measure the whole process will see the benefit. Practices that simply turn the feature on may end up with the same delays in a new format.

EMB Integrated Health Solutions helps small and specialty practices redesign prior authorization and patient access workflows, evaluate EHR capabilities, and build the procedures and metrics that make new technology work. If you are preparing for 2027, we would be glad to talk.

Sources

  1. Lauffenburger JC, Stults CD, Mudiganti S, et al. Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system. J Am Med Inform Assoc. 2021;28(10):2233-2240. doi:10.1093/jamia/ocab119

  2. Centers for Medicare & Medicaid Services. CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) fact sheet. January 17, 2024.

  3. Centers for Medicare & Medicaid Services. Interoperability frequently asked questions: general.

  4. Centers for Medicare & Medicaid Services. Prior Authorization API workflow and recommended implementation guides.

  5. Centers for Medicare & Medicaid Services. Overview of the 2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P).

  6. Centers for Medicare & Medicaid Services. Summary of proposed provisions, CMS-0062-P. April 2026.

  7. Centers for Medicare & Medicaid Services. CY 2027 Quality Payment Program final rule fact sheet. November 2026.

This article is for general information and is not legal or regulatory advice. Requirements and dates can change, so confirm them with CMS, your payers, and your EHR vendor.

 
 

©2024-2026 by EMB Integrated Health Solutions LLC.
Our services are consultative and do not constitute legal, tax or clinical advice.

bottom of page